| Robert Howes Montgomery, MD | |
|
9447 Discovery Ter, #202, Bradenton, FL 34212-5113 | |
| (941) 567-4700 | |
| Not Available |
| Full Name | Robert Howes Montgomery |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 9447 Discovery Ter, Bradenton, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235421645 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 13018 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert Howes Montgomery, MD 9447 Discovery Ter, #202, Bradenton, FL 34212-5113 Ph: (941) 567-4700 | Robert Howes Montgomery, MD 9447 Discovery Ter, #202, Bradenton, FL 34212-5113 Ph: (941) 567-4700 |
News Archive
The ATG16L1 gene is located on chromosome 2 and encodes a protein involved in the formation of autophagosomes during autophagy. Autophagy is a cytoplasmic process that keeps a cell stable. Hampe et al first identified ATG16L1 as a Crohn's disease (CD) susceptibility gene in 2007, and many other studies have arisen since then. However, the definite relationship of variants of ATG16L1 with IBD remains unclear.
Summer heat waves significantly increase pressure on hospitals, according to research published in the online open access journal, BMC Public Health.
Kaiser Health News provides a fresh perspective on health policy developments with "Love, Mitch?" By John Cole, Scranton Times-Tribune
Western States Biopharmaceuticals, Inc., a privately-held biotechnology company focusing on the development of novel therapies to treat inflammatory disease, and the University of Colorado announced today that they have entered into a licensing agreement for approaches to inhibiting newly discovered T cell Cytokine Inducing Surface Molecules, or TCISM autoimmune disease drug discovery targets.
Ocugen, Inc. and the University of Colorado today announced exclusive license agreements that allow for Ocugen to continue developing two drug candidates for the treatment for ophthalmology indications, and that one of the assets, OCU100, recombinant lens epithelium derived growth factor 1-326 (LEDGF1-326), received orphan-drug status from the U.S. Food and Drug Administration for treatment of retinitis pigmentosa (RP), a rare eye disease.
› Verified 4 days ago
Mr. Denis M Cavanagh, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 300 Riverside Drive E, Suite 4300, Bradenton, FL 34208 Phone: 941-747-3034 Fax: 941-748-8077 | |
Scott Blanchard, RDMS Radiology Medicare: Not Enrolled in Medicare Practice Location: 1505 21st St W, Bradenton, FL 34205 Phone: 941-920-2332 | |
Dr. Steven Lipman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 8340 Lakewood Ranch Blvd, Bradenton, FL 34202 Phone: 941-782-3053 | |
Dr. Lawrence George Manco, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 206 2nd St E, Bradenton, FL 34208 Phone: 941-955-4101 Fax: 941-358-9817 | |
Dr. Richard Gerard Bilodeau, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 206 2nd Street East, Bradenton, FL 34208 Phone: 941-955-4101 | |
Dr. Sean Xavier Cavanaugh, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 401 Manatee Ave E Ste A, Bradenton, FL 34208 Phone: 941-748-4324 Fax: 941-748-7878 |